Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Recenti Progressi in Medicina|October 1, 1989
[Granulocyte disease caused by glycoprotein complex deficiency correlated with leukocyte adhesion]G Ricevuti, A Mazzone, D Pasotti, et al.Recenti Progressi in Medicina|October 1, 1989
[Presentation of 2 clinical cases of deficiency of granulocyte membrane glycoproteins]G Ricevuti, A Mazzone, D Pasotti, et al.International Journal of Immunopathology and Pharmacology|January 20, 2011
Chronic fatigue syndrome/myalgic encephalomyelitis: an updateE Capelli, R Zola, L Lorusso, et al.Medicina (Florence, Italy)|July 1, 1989
[Breast and skin localization of non-Hodgkin's lymphoma. Description of a clinical case]G Ricevuti, D Pasotti, A Mazzone, et al.Recenti Progressi in Medicina|November 1, 1996
[Opioid receptors and phagocyte defects in drug addicts]A Mazzone, G Fossati, I Mazzucchelli, et al.International Journal of Immunopathology and Pharmacology|November 13, 2003
CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated plateletsN C Kaneider, A Kaser, H Tilg, et al.European Heart Journal|September 1, 1990
Increased neutrophil aggregability in coronary artery diseaseG Ricevuti, S De Servi, A Mazzone, et al.Drugs Under Experimental and Clinical Research|January 1, 1985
Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbitL Favalli, E Lanza, A Rozza Dionigi, et al.International Journal of Immunopharmacology|January 1, 1989
A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activationM Marcoli, G Ricevuti, A Mazzone, et al.International Journal of Immunopharmacology|January 1, 1988
Opioid-induced modification of granulocyte functionM Marcoli, G Ricevuti, A Mazzone, et al.Pageof 10